Position Paper: for an ambitious EU industrial strategy

SPC manufacturing waiver

Addressing medicine shortages in Europe

Reading List | Medicine Shortages

Position Paper Medicines Shortages

Fighting counterfeit medicines in Europe: the effect on access to medicines

The implementation of the Falsified Medicines Directive, and its Delegated Regulation with detailed specifications of safety features, will provide an additional obstacle for counterfeiters. The implementation of the Directive aims to prevent falsified medicines from reaching patients, and is in the interest of public health. However, the financial burden for manufacturers to implement these additional safety features, as well as the repository system that will allow the verification of authenticity of individual packs of medicine, may threaten the availability of medicines.

Authors

Maarten Van Baelen, Pieter Dylst, Catarina Lopes Pereira, Johan Verhaeghe, Koen Nauwelaerts, Susie Lyddon

Read more

Join Medicines for Europe – 2017

Medicines for Europe Country Specific Market Access Policies

Universal Access to Health, How Can We Contribute?

AGENDA

9.30 Coffee & Registration

10.00 Introduction: the event, rationale of the partnership, 4th edition, goal of the debate, setting

Moderator:  Sarantis Michalopoulos, Euractiv

10.15 Welcome Address and MEPs’ perspectives

  • MEP José Inácio Faria, EPP group, PT
  • MEP Andrey Kovatchev, EPP group, BU

10.30 European Commission’s overview

  • Sylvain Giraud, Head of Unit, DG Santé

10.45 Stakeholders’ perspectives on improving access to healthcare

  • Nicola Bedlington (EPF)
  • Arnaud Emériau (ESIP)
  • Yannis Natsis (EPHA)
  • Adrian van den Hoven (Medicines for Europe)

11:45  Exchange of views

12:15  Questions and answers

12.30  Networking Lunch

REGISTRATION

Medicines for Europe – Better Access. Better Health